SG11201908066XA - Radioactive fluorine-labeled precursor compound, and method for producing radioactive fluorine-labeled compound using same - Google Patents

Radioactive fluorine-labeled precursor compound, and method for producing radioactive fluorine-labeled compound using same

Info

Publication number
SG11201908066XA
SG11201908066XA SG11201908066XA SG11201908066XA SG11201908066XA SG 11201908066X A SG11201908066X A SG 11201908066XA SG 11201908066X A SG11201908066X A SG 11201908066XA SG 11201908066X A SG11201908066X A SG 11201908066XA SG 11201908066X A SG11201908066X A SG 11201908066XA
Authority
SG
Singapore
Prior art keywords
labeled
radioactive fluorine
compound
carbon atoms
same
Prior art date
Application number
SG11201908066XA
Inventor
Masato KIRIU
Hiroaki Ichikawa
Yuki Okumura
Hiroshi Tanaka
Original Assignee
Nihon Mediphysics Co Ltd
Tokyo Inst Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd, Tokyo Inst Tech filed Critical Nihon Mediphysics Co Ltd
Publication of SG11201908066XA publication Critical patent/SG11201908066XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/72Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/76Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/72Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/77Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing carboxyl groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/22Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of halogens; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/17Unsaturated ethers containing halogen
    • C07C43/174Unsaturated ethers containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

There is provided a labeling precursor compound represented by the general formula (2): wherein S represents a substrate, L represents a straight 5 alkyl group having 1 to 6 carbon atoms which may contain an ether group, R1 and R2 each independently represent a straight or branched alkyl group having 1 to 30 carbon atoms, or a substituted or unsubstituted monocyclic or condensed polycyclic aryl group, R3 each independently 10 represent an alkyl group having 1 to 4 carbon atoms or an alkoxy group having 1 to 4 carbon atoms, and p represents an integer of 0 to 4.
SG11201908066XA 2017-03-07 2018-03-05 Radioactive fluorine-labeled precursor compound, and method for producing radioactive fluorine-labeled compound using same SG11201908066XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017042783 2017-03-07
PCT/JP2018/008287 WO2018164043A1 (en) 2017-03-07 2018-03-05 Radioactive fluorine-labeled precursor compound, and method for producing radioactive fluorine-labeled compound using same

Publications (1)

Publication Number Publication Date
SG11201908066XA true SG11201908066XA (en) 2019-09-27

Family

ID=63448846

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201908066XA SG11201908066XA (en) 2017-03-07 2018-03-05 Radioactive fluorine-labeled precursor compound, and method for producing radioactive fluorine-labeled compound using same

Country Status (10)

Country Link
US (1) US20200009273A1 (en)
EP (1) EP3594200B1 (en)
JP (1) JP7165853B2 (en)
KR (1) KR20190126357A (en)
CN (1) CN110312704A (en)
AU (1) AU2018232211A1 (en)
CA (1) CA3055417A1 (en)
ES (1) ES2909126T3 (en)
SG (1) SG11201908066XA (en)
WO (1) WO2018164043A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022110777A (en) 2021-01-19 2022-07-29 国立大学法人東京工業大学 Radioactive halogen-labeled precursor compound

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19727812A1 (en) 1997-06-30 1999-01-07 Technoworld Gmbh Training device
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
ES2663496T3 (en) * 2005-11-29 2018-04-13 Nihon Medi-Physics Co., Ltd. Precursor compound of radioactive halogen-labeled organic compound
CN101466711A (en) * 2006-05-19 2009-06-24 日本医事物理股份有限公司 Novel compound having affinity for amyloid
ATE535527T1 (en) 2006-05-19 2011-12-15 Nihon Mediphysics Co Ltd CONNECTION WITH AFFINITY TO AMYLOID
AU2007337481B2 (en) * 2006-12-27 2012-02-09 Nihon Medi-Physics Co., Ltd. Process for production of precursor compound for radioactive halogen-labeled organic compound
EP2110367A1 (en) * 2008-04-14 2009-10-21 Bayer Schering Pharma Aktiengesellschaft Purification strategy for direct nucleophilic procedures
GB0821432D0 (en) * 2008-11-24 2008-12-31 Gen Electric Imaging ligands
CA2767470A1 (en) 2009-07-11 2011-01-20 Bayer Pharma Aktiengesellschaft Non-polar and polar leaving groups
EP3162802B1 (en) 2014-06-26 2020-08-19 Nihon Medi-Physics Co., Ltd. 2-(3-pyridinyl)-1h-benzimidazole derivative compound and medicine containing same
JP2017042783A (en) 2015-08-26 2017-03-02 昭和電工株式会社 Method for manufacturing heat radiation substrate
JP6523107B2 (en) 2015-09-08 2019-05-29 日本メジフィジックス株式会社 Radioactive fluorine labeled precursor compound and method for producing radioactive fluorine labeled compound using the same

Also Published As

Publication number Publication date
AU2018232211A1 (en) 2019-09-26
US20200009273A1 (en) 2020-01-09
EP3594200A1 (en) 2020-01-15
JP7165853B2 (en) 2022-11-07
JPWO2018164043A1 (en) 2020-01-09
ES2909126T3 (en) 2022-05-05
EP3594200A4 (en) 2020-03-11
CN110312704A (en) 2019-10-08
EP3594200B1 (en) 2022-03-02
KR20190126357A (en) 2019-11-11
CA3055417A1 (en) 2018-09-13
WO2018164043A1 (en) 2018-09-13

Similar Documents

Publication Publication Date Title
PH12016500091A1 (en) Quaternary ammonium compounds as fuel or lubricant additives
MX370398B (en) Glucoside compound, method for producing thioether, ether, method for producing ether, method for producing glucoside compound, method for producing nucleic acid.
EP3051350A3 (en) Alcoholic compound and method for producing alcoholic compound
MX2013006926A (en) Photochromic compounds and compositions.
MY167604A (en) Coupling agent for rubber/carbon black, and rubber composition containing same for use in tires
EP2520579A3 (en) A silicone compound, photocurable liquid ink using the silicone compound, and method of manufacturing the ink
EP4230631A3 (en) Process for making trisubstituted silyloxyethyl triflates
IN2012DN01815A (en)
IN2014MN01521A (en)
IN2014CN02843A (en)
UY36885A (en) COMPOUND FOR USE IN COMPOSITIONS THAT CHANGE COLOR
MY179698A (en) Distilllable fuel markers
AR066191A1 (en) PROCESS AND INTERMEDIARIES FOR THE SYNTHESIS OF COMPOUNDS 8- [(1- (3,5- BIS- (TRIFLUOROMETIL) PHENYL) - ETOXI) - METAL] - 8 PHENYL - 1,7- DIAZA - ESPIRO (4, 5) DECAN - 2 ONA
MX2022007662A (en) Synthesis of compounds to promote hair growth.
GB2470170A (en) Dithienothiophene derivatives
IN2014DN07169A (en)
UA111950C2 (en) HETEROCYCLIC COMPOUNDS FOR TREATMENT OR PREVENTION OF DISORDERS CAUSED BY REDUCED NERROTRANSMISSION OF SEROTONIN, NOREPINEPHIN OR DOPIN
SG11201908066XA (en) Radioactive fluorine-labeled precursor compound, and method for producing radioactive fluorine-labeled compound using same
CY1112279T1 (en) EPOXY UNION AND METHOD FOR PREPARING IT
WO2016097657A3 (en) Polyaromatic dimers, method for preparing same and use of same
WO2013083966A3 (en) Tracers and method of marking hydrocarbon liquids
CO6680619A2 (en) Formulations
SE1100784A1 (en) New phosphate compound
EA201070245A1 (en) NEW INHIBITORS γ-SECRETASES
IN2012DN01251A (en)